mito-extra® - medac GmbH

56
T
U
V
Z
Tiermodell ..................................................................... 22, 52
Toxizität ................................................ 4, 7, 15, 40, 43, 51, 53
Trauma ............................................................................... 22
Tumorzellimplantation ............................ 22, 23, 24, 25, 30, 31
Überlebensrate ....................................................... 43, 46, 49
Urinzytologie ....................................................................... 23
Vitamin B6 .......................................................................... 07
Zystitis ........................................................................ 5, 6, 44
Zytotoxizitä ............................................................. 15, 22, 24